'''Fresenius Kabi announced today it has launched GadoterateMeglumine Injection, USP, a bioequivalent and therapeutic equivalent substitute for the contrast agent Dotarem®*. This is the ...'
'''Guerbet announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem (gadoteratemeglumine), a gadolinium-based contrast agent (GBCA) indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine ...'
If an elderly but distinguished scientist says that something is
possible he is almost certainly right, but if he says that it is impossible
he is very probably wrong. - Arthur C. Clarke
•
News
top
